The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Gallic Acid Alleviates Gouty Arthritis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Through Enhancing Nrf2 Signaling
Open accessAbstract
Gallic acid is an active phenolic acid widely distributed in plants, and there is compelling evidence to prove its anti-inflammatory effects. NLRP3 inflammasome dysregulation is closely linked to many inflammatory diseases. However, how gallic acid affects the NLRP3 inflammasome remains unclear. Therefore, in the present study, we investigated the mechanisms underlying the effects of gallic acid on the NLRP3 inflammasome and pyroptosis, as well as its effect on gouty arthritis in mice. The results showed that gallic acid inhibited lactate dehydrogenase (LDH) release and pyroptosis in lipopolysaccharide (LPS)-primed and ATP-, nigericin-, or monosodium urate (MSU) crystal-stimulated macrophages. Additionally, gallic acid blocked NLRP3 inflammasome activation and inhibited the subsequent activation of caspase-1 and secretion of IL-1β. Gallic acid exerted its inhibitory effect by blocking NLRP3-NEK7 interaction and ASC oligomerization, thereby limiting inflammasome assembly. Moreover, gallic acid promoted the expression of nuclear factor E2-related factor 2 (Nrf2) and reduced the production of mitochondrial ROS (mtROS). Importantly, the inhibitory effect of gallic acid could be reversed by treatment with the Nrf2 inhibitor ML385. NRF2 siRNA also abolished the inhibitory effect of gallic acid on IL-1β secretion. The results further showed that gallic acid could mitigate MSU-induced joint swelling and inhibit IL-1β and caspase 1 (p20) production in mice. Moreover, gallic acid could moderate MSU-induced macrophages and neutrophils migration into joint synovitis. In summary, we found that gallic acid suppresses ROS generation, thereby limiting NLRP3 inflammasome activation and pyroptosis dependent on Nrf2 signaling, suggesting that gallic acid possesses therapeutic potential for the treatment of gouty arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis
Yamamoto, M., Kensler, T. W., & Motohashi, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2017 · Cited by 1,968
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2725 · Cited by 1,850
Reactive oxygen species and mitochondria: A nexus of cellular homeostasis
Dan Dunn, J., Alvarez, L. A., Zhang, X., & Soldati, T. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.005 · Cited by 1,203
The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages
Evavold, C. L., Ruan, J., Tan, Y., Xia, S., Wu, H., & Kagan, J. C. (2018) · Immunity · doi:10.1016/j.immuni.2017.11.013 · Cited by 1,115 · cited 1×
“IL-1b can induce neutrophil infiltration into joints, leading to articular swelling and pain (17, 18).”
BackgroundOridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
He, H., Jiang, H., Chen, Y., Ye, J., Wang, A., Wang, C., Liu, Q., Liang, G., Deng, X., Jiang, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04947-6 · Cited by 827
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
Sharif, H., Wang, L., Wang, W. L., Magupalli, V. G., Andreeva, L., Qiao, Q., Hauenstein, A. V., Wu, Z., Núñez, G., Mao, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1295-z · Cited by 824
Shi, H., Wang, Y., Li, X., Zhan, X., Tang, M., Fina, M., Su, L., Pratt, D., Bu, C. H., Hildebrand, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3333 · Cited by 745
Self-citationPtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
Chen, J., & Chen, Z. J. (2018) · Nature · doi:10.1038/s41586-018-0761-3 · Cited by 692
Inflammation in gout: mechanisms and therapeutic targets
So, A. K., & Martinon, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.155 · Cited by 608
Tranilast directly targets NLRP 3 to treat inflammasome‐driven diseases
Huang, Y., Jiang, H., Chen, Y., Wang, X., Yang, Y., Tao, J., Deng, X., Liang, G., Zhang, H., Jiang, W., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708689 · Cited by 507
Han, Y., Xu, X., Tang, C., Gao, P., Chen, X., Xiong, X., Yang, M., Yang, S., Zhu, X., Yuan, S., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.013 · Cited by 458
Inflammation and Oxidative Stress in an Obese State and the Protective Effects of Gallic Acid
Dludla, P. V., Nkambule, B. B., Jack, B., Mkandla, Z., Mutize, T., Silvestri, S., Orlando, P., Tiano, L., Louw, J., & Mazibuko-Mbeje, S. E. (2018) · Nutrients · doi:10.3390/nu11010023 · Cited by 286
Wang, P., Geng, J., Gao, J., Zhao, H., Li, J., Shi, Y., Yang, B., Xiao, C., Linghu, Y., Sun, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08680-6 · Cited by 261
Self-citationPazár, B., Ea, H.-K., Narayan, S., Kolly, L., Bagnoud, N., Chobaz, V., Roger, T., Lioté, F., So, A., & Busso, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001284 · Cited by 255
Alkyl esters of gallic acid as anticancer agents: A review
Locatelli, C., Filippin-Monteiro, F. B., & Creczynski‐Pasa, T. B. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.056 · Cited by 232
Honda, H., Nagai, Y., Matsunaga, T., Okamoto, N., Watanabe, Y., Tsuneyama, K., Hayashi, H., Fujii, I., Ikutani, M., Hirai, Y., et al. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0114-005rr · Cited by 211
Yin, H., Guo, Q., Li, X., Tang, T., Li, C., Wang, H., Sun, Y., Feng, Q., Ma, C., Gao, C., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701495 · Cited by 208
Self-citationProbing Gallic Acid for Its Broad Spectrum Applications
Choubey, S., Goyal, S., Varughese, L. R., Kumar, V., Sharma, A. K., & Beniwal, V. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557518666180330114010 · Cited by 161
Gallic acid: prospects and molecular mechanisms of its anticancer activity
Subramanian, A. P., John, A., Vellayappan, M. V., Balaji, A., Jaganathan, S. K., Supriyanto, E., & Yusof, M. (2015) · RSC Advances · doi:10.1039/c5ra02727f · Cited by 160
Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis
Zhu, L., Gu, P., & Shen, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.049 · Cited by 160
Tanaka, M., Kishimoto, Y., Sasaki, M., Sato, A., Kamiya, T., Kondo, K., & Iida, K. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9364364 · Cited by 154
Hsiang, C., Hseu, Y., Chang, Y., Kumar, K. J. S., Ho, T., & Yang, H. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.08.009 · Cited by 122
Gallic Acid and Gallates in Human Health and Disease: Do Mitochondria Hold the Key to Success?
Kosuru, R. Y., Roy, A., Das, S. K., & Bera, S. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700699 · Cited by 109
Gallic Acid Attenuated LPS-Induced Neuroinflammation: Protein Aggregation and Necroptosis
Liu, Y., Hsu, C., Huang, H.-J., Chang, C., Sun, S.-H., & Lin, A. M. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01759-7 · Cited by 105
Dong, Z., Shang, H., Chen, Y. Q., Pan, L., Bhatia, M., & Sun, J. T. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7864150 · Cited by 100
Pan, H., Lin, Y., Dou, J., Fu, Z. F., Yao, Y., Ye, S., Zhang, S., Wang, N., Liu, A., Li, X., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12868 · Cited by 81
Self-citationRadan, M., Dianat, M., Badavi, M., Mard, S. A., Bayati, V., & Goudarzi, G. (2018) · Free Radical Research · doi:10.1080/10715762.2018.1563689 · Cited by 80
Gallic acid protects against the COPD-linked lung inflammation and emphysema in mice
Singla, E., Dharwal, V., & Naura, A. S. (2020) · Inflammation Research · doi:10.1007/s00011-020-01333-1 · Cited by 65
Epigallocatechin gallate inhibits urate crystals‐induced peritoneal inflammation in C57BL/6 mice
Jhang, J., Lu, C., & Yen, G. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600106 · Cited by 64
Pan, H., Xu, L., Huang, M.-Y., Zha, Q., Zhao, G., Hou, X.-F., Shi, Z., Lin, Q.-R., Ouyang, D., & He, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5957 · Cited by 41
Self-citationPan, H., Xu, L., Ouyang, D., Wang, Y., Zha, Q.-B., Hou, X., & He, X. (2014) · Inflammation · doi:10.1007/s10753-013-9794-9 · Cited by 30
Self-citation
Cited by
Rudrapal, M., Rakshit, G., Singh, R. P., Garse, S., Khan, J., & Chakraborty, S. (2024) · Antioxidants · doi:10.3390/antiox13040429 · Cited by 259
Zhou, Y., Tang, J., Lan, J., Zhang, Y., Wang, H., Chen, Q., Kang, Y., Sun, Y., Feng, X., Wu, L., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.019 · Cited by 80
Metadata
- Authors
- Lin, Y., Luo, T., Weng, A., Huang, X., Yao, Y., Fu, Z., Li, Y., Liu, A., Li, X., Chen, D., & Pan, H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-07
- Volume
- 11
- Pages
- 580593-580593
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3111759303
- Cited by
- 283
- References
- 34
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.